Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Randomized treatment of patients with stable coronary artery disease with the AT(1)-R blocker telmisartan significantly increased the number of circulating CD34/KDR-positive EPCs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• assertion description "[Randomized treatment of patients with stable coronary artery disease with the AT(1)-R blocker telmisartan significantly increased the number of circulating CD34/KDR-positive EPCs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP865334.RATznFEMHCsZ7kPulQlfKYo8T27s6PrdalhpKVMe8F6GA130_assertion description "[Randomized treatment of patients with stable coronary artery disease with the AT(1)-R blocker telmisartan significantly increased the number of circulating CD34/KDR-positive EPCs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP865334.RATznFEMHCsZ7kPulQlfKYo8T27s6PrdalhpKVMe8F6GA130_provenance.
• assertion description "[Randomized treatment of patients with stable coronary artery disease with the AT(1)-R blocker telmisartan significantly increased the number of circulating CD34/KDR-positive EPCs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Randomized treatment of patients with stable coronary artery disease with the AT(1)-R blocker telmisartan significantly increased the number of circulating CD34/KDR-positive EPCs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP333685.RAkpIS4bbuveq22FHHum41L8wK-KuRPZWfNsb4GgzSeHw130_assertion description "[Randomized treatment of patients with stable coronary artery disease with the AT(1)-R blocker telmisartan significantly increased the number of circulating CD34/KDR-positive EPCs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP333685.RAkpIS4bbuveq22FHHum41L8wK-KuRPZWfNsb4GgzSeHw130_provenance.
• NP418465.RAeS1GkN4-5fk2E52TzfWY-h_4p5b18mOet0A6Js2bcCY130_assertion description "[Randomized treatment of patients with stable coronary artery disease with the AT(1)-R blocker telmisartan significantly increased the number of circulating CD34/KDR-positive EPCs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP418465.RAeS1GkN4-5fk2E52TzfWY-h_4p5b18mOet0A6Js2bcCY130_provenance.
• NP610824.RAw-KBhXxMT71gJfqYSh945kQ0PvKi-l1F_ytXZdeCa3s130_assertion description "[Randomized treatment of patients with stable coronary artery disease with the AT(1)-R blocker telmisartan significantly increased the number of circulating CD34/KDR-positive EPCs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP610824.RAw-KBhXxMT71gJfqYSh945kQ0PvKi-l1F_ytXZdeCa3s130_provenance.
• NP538602.RA7C2PPSld6v0TgZ_uX-P8yqo92_v3v0BTqm6ps60fS_8130_assertion description "[Randomized treatment of patients with stable coronary artery disease with the AT(1)-R blocker telmisartan significantly increased the number of circulating CD34/KDR-positive EPCs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP538602.RA7C2PPSld6v0TgZ_uX-P8yqo92_v3v0BTqm6ps60fS_8130_provenance.
• NP716479.RA9W-S2eMdqsMsdL_tAoHpUtlquS8NVqDuXw5UZxdomss130_assertion description "[Randomized treatment of patients with stable coronary artery disease with the AT(1)-R blocker telmisartan significantly increased the number of circulating CD34/KDR-positive EPCs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP716479.RA9W-S2eMdqsMsdL_tAoHpUtlquS8NVqDuXw5UZxdomss130_provenance.
• NP813842.RALvPE4QcDzWVDXYmt90vznQjKz-hKZh9OVqidOVohDBU130_assertion description "[Randomized treatment of patients with stable coronary artery disease with the AT(1)-R blocker telmisartan significantly increased the number of circulating CD34/KDR-positive EPCs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP813842.RALvPE4QcDzWVDXYmt90vznQjKz-hKZh9OVqidOVohDBU130_provenance.
• NP230411.RA6gN7WXPTjHWKQ1HpGbzt27w0hb4ShSUbzdnJgmrJypU130_assertion description "[Randomized treatment of patients with stable coronary artery disease with the AT(1)-R blocker telmisartan significantly increased the number of circulating CD34/KDR-positive EPCs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP230411.RA6gN7WXPTjHWKQ1HpGbzt27w0hb4ShSUbzdnJgmrJypU130_provenance.
• NP229931.RAJjcLr9YTmzvMQUFqkCGXST-dZP7EaJJ_my4c7ICHngw130_assertion description "[Randomized treatment of patients with stable coronary artery disease with the AT(1)-R blocker telmisartan significantly increased the number of circulating CD34/KDR-positive EPCs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP229931.RAJjcLr9YTmzvMQUFqkCGXST-dZP7EaJJ_my4c7ICHngw130_provenance.
• NP229943.RAOcA1RhhQXZ49yDe20qAcGhWOJtMt1xT7m-8hjeorp_0130_assertion description "[Randomized treatment of patients with stable coronary artery disease with the AT(1)-R blocker telmisartan significantly increased the number of circulating CD34/KDR-positive EPCs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP229943.RAOcA1RhhQXZ49yDe20qAcGhWOJtMt1xT7m-8hjeorp_0130_provenance.
• NP915537.RAdpRBMBkyRl4SC6DwE6N1KroeEcqPKMmYOwbf6TJRd3U130_assertion description "[Randomized treatment of patients with stable coronary artery disease with the AT(1)-R blocker telmisartan significantly increased the number of circulating CD34/KDR-positive EPCs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP915537.RAdpRBMBkyRl4SC6DwE6N1KroeEcqPKMmYOwbf6TJRd3U130_provenance.
• NP915539.RARkpigCaIpelKWl3WqPVew7lsn4jVD85i-5su10AUknY130_assertion description "[Randomized treatment of patients with stable coronary artery disease with the AT(1)-R blocker telmisartan significantly increased the number of circulating CD34/KDR-positive EPCs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP915539.RARkpigCaIpelKWl3WqPVew7lsn4jVD85i-5su10AUknY130_provenance.
• NP915540.RAbaPakDDMuVBE87e6iWX3L0_DEfkcYBGYjKwN6c4gGMM130_assertion description "[Randomized treatment of patients with stable coronary artery disease with the AT(1)-R blocker telmisartan significantly increased the number of circulating CD34/KDR-positive EPCs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP915540.RAbaPakDDMuVBE87e6iWX3L0_DEfkcYBGYjKwN6c4gGMM130_provenance.